Stock News

Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®
Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript
Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings
Biogen Stock Rises After Earnings, Jump in Sales of Alzheimer’s Drug
Biogen stock rises on Q1 results, Alzheimer's drug sales
Alzheimer’s Drug Leqembi Sees Sales Pickup, Boosting Biogen Stock

As seen on...